Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.35 CHF | -0.74% | -3.52% | -5.10% |
04-25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
04-25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.10% | 95.29M | |
+3.09% | 69.85B | |
+11.77% | 8.98B | |
-14.44% | 4.89B | |
+41.60% | 4.44B | |
+5.96% | 3.95B | |
+22.70% | 2.49B | |
-19.32% | 2.4B | |
-27.04% | 2.28B | |
+7.97% | 1.96B |
- Stock Market
- Equities
- SANN Stock
- News Santhera Pharmaceuticals Holding AG
- Santhera Pharmaceuticals : Meets Primary Endpoint For Vamorolone In Duchenne Muscular Dystrophy; Shares Soar 50%